RIO DE JANEIRO (Reuters) – Brazilian pharmaceutical sector associations on Friday called for the rejection of a bill that seeks to suspend COVID-19 vaccine patents, saying it could spark international retaliation and reduce medical supplies in Latin America’s biggest country.
Brazil’s Senate passed the proposal, which the government opposes, on Thursday night, sending it to the lower house for consideration.
(Reporting by Gabriel Stargardter; Editing by Brad Haynes)
